Skip to main content

Table 1 Descriptive analysis of the hemodialysis population

From: Serum osteoprotegerin in prevalent hemodialysis patients: associations with mortality, atherosclerosis and cardiac function

Patients (n)

220

Age (years)

61.1 ± 6.1

Sex (male/female)

154 (70%) / 66 (30%)

Charlson Comorbidity Index

5.76 ± 2.46

Body mass index (BMI) (Kg/m2)

24.33 ± 4.39

Time on HD (months) (median)

31 [9, 77.7]

Previous kidney transplant

51 (23.2%)

Smoking (yes/no/former)

35/130/55 (15.9%/59.1%/25%)

Diabetes mellitus (yes/no)

56 (25.5%)/164 (74.5%)

Hypertension (yes/no)

194 (88.2%)/26(11.8%)

Dyslipidaemia (yes/no)

84 (38.2%)/136 (61.8%)

IMT, mean (mm)

0.789 ± 0.282

IMT > 0.9 mm

35 (15.9%)

Presence of Plaques

85 (84.2%)

Calcified Plaques

69 (68.4%)

Presence of Stenosis

40 (72.3%)

LVH (%)

54 (24.5%)

LVMI (g/m2)

96.27 ± 26.07

LV ejection fraction (%)

58.34 ± 10.73

  1. Data are shown as mean ± SD or cases (percentage) unless otherwise specified